miR-6089 Alleviates Inflammation and Cell Apoptosis Through Modulating the TLR4 Pathway in Mite-Sensitized Allergic...

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Allergic rhinitis (AR) is a chronic Th2-mediated inflammatory nasal disease.
• MicroRNAs (miRNAs) are implicated in AR pathogenesis, but their specific roles and therapeutic potential require further elucidation.

Purpose of the Study:

• To investigate the molecular mechanisms of miRNAs in allergic rhinitis.
• To explore the therapeutic potential of microRNAs, specifically miR-6089, in AR.

Main Methods:

• miRNA and mRNA sequencing of nasal mucosa from AR patients and controls.
• Bioinformatic analyses (GO, KEGG) to identify enriched pathways.
• Luciferase reporter assays to validate miRNA-target interactions.
• In vitro AR cell models using lipopolysaccharide (LPS) to assess miR-6089 function.

Main Results:

• Differential expression analysis revealed 28 miRNAs and 172 mRNAs in AR nasal mucosa.
• Enriched pathways included TLR, NF-κB, and IL-17 signaling.
• miR-6089 expression was decreased, while TLR4, IL-6, IL-8, and TSLP were increased in AR.
• miR-6089 directly targets TLR4 and mitigates LPS-induced inflammation in human nasal epithelial cells.

Conclusions:

• miR-6089 plays a protective role by targeting TLR4, reducing inflammation in AR.
• miR-6089 represents a promising therapeutic target for mite-sensitized allergic rhinitis.